Investor Presentation for the quarter and half year ended 30th September 2026

SUMITOMO CHEMICAL INDIA LTD. Corporate Office: 13/14, Aradhana IDC, Near Virwani Industrial Estate, Goregaon (East), Corporate Identity Number (CIN) – L24110MH2000PLC124224 Mumbai – 400 063, Maharashtra, INDIA. Tel. : +91-22-4252 2200 / Fax : +91-22-4252 2380 URL http://www.sumichem-india.co.in 26th October, 2026 BSE Limited, The National Stock Exchange of India, Listing Department, Listing Department, Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra East, Mumbai – 400 051 Scrip Code: 542920 Scrip Symbol: SUMICHEM Subject: Investor Presentation on Financial Results of the Company for the quarter and half-year ended 30th September, 2026. Dear Sirs, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith investor presentation on the Financial Results of the Company for the quarter and half-year ended 30th September, 2026. Kindly do the needful to display the same on your website. Thanking You, Yours faithfully, For Sumitomo Chemical India Limited Deepika Trivedi Company Secretary & Compliance Officer Encl.: a/a Registered Office: Building No. 1, Ground Floor, Shant Manor Co-op. Housing Society Ltd., Chakravarti Ashok ‘X’ Road, Kandivli (East), Mumbai – 400 101, Maharashtra, INDIA. Sumitomo Chemical India Limited Investor Presentation - September 2026 STABILITY A YEAR OF Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Sumitomo Chemical India Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment what so ever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company’s future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its exposure to market risks, as well as other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company isnot responsible for such third party statements and projections. SCIL Innovate Nurture Grow Financial Performance & Key Highlights Performance Highlights – Quarter Revenue (Rs Crs) Gross Profit (Rs. Crs) & Historical Q2 Performance Trend Gross Profit Margin (%) Gross Profit Margin % EBITDA Margin % PAT Margin % 930 907 369 43.1% 40.7% 1200.0 1121.7 43.1% 45.0% 42.6% 40.7% 39.0% 38.4% 988.3 40.0% 37.9% 1000.0 929.8 910.4 907.3 903.5 35.0% s e 800.0 Q2FY26 Q2FY27 Q2FY26 Q2FY27 r o r 30.0% EBITDA (Rs. Crs) & PAT (Rs Crs) .s 600.0 23.6% 24.8% 20.8% 24.8% 23.4% 25.0% EBITDA Margin (%) PAT Margin (%) ( e 20.5% u 20.0% e 400.0 v 19.5% -15% -11% e R 16.9% 18.0% 15.9% 19.1% 17.3% 15.0% 218 178 200.0 186 10.0% 0.0 5.0% 23.4% Q2FY22 Q2FY23 Q2FY24 Q2FY25 Q2FY26 Q2FY27 20.5% 19.1% 17.3% Q2FY26 Q2FY27 Q2FY26 Q2FY27 Given the seasonality in the business, it is best monitored on an annual basis SCIL Innovate Nurture Grow Performance Highlights – H1FY27 Revenue (Rs Crs) Gross Profit (Rs. Crs) & Historical Half-yearly Performance Trend Gross Profit Margin (%) Gross Profit Margin % EBITDA Margin % PAT Margin % 803 786 1,987 1,971 2500.0 45.0% 40.4% 39.9% 40.9% 40.4% 39.9% 2,106.4 40.0% 37.7% 1,986.6 2000.0 35.1% 1,970.7 1,827.2 36.6% 35.0% 1,692.4 ) s 1,627.7 H1FY26 H1FY27 H1FY26 H1FY27 r o r1500.0 30.0% EBITDA (Rs. Crs) & PAT (Rs Crs) & .s 22.0% 21.3% 25.0% R 21.5% 22.1% 22.2% EBITDA Margin (%) PAT Margin (%) ( e1000.0 u 16.5% 20.0% +5% v 18.9% -4% e R 17.5% 17.9% 15.0% 437 419 356 372 500.0 15.4% 16.1% 12.6% 10.0% 0.0 5.0% H1FY22 H1FY23 H1FY24 H1FY25 H1FY26 H1FY27 22.0% 21.3% 17.9% 18.9% H1FY26 H1FY27 H1FY26 H1FY27* *Q1FY27 includes an Exceptional Item of Rs. 26.9 crore, representing the insurance claim received towards business interruption arising from the fire incident at the Company's Bhavnagar plant during FY23. Given the seasonality in the business, it is best monitored on an annual basis SCIL Innovate Nurture Grow Performance Highlights – Q2 & H1 FY27 ✓ The Indian agrochemical industry faced a challenging operating environment during H1FY27, with delayed monsoon onset, prolonged dry spells and a 13% rainfall deficit impacting crop sowing and agrochemical consumption. Weak seasonal demand affected offtake across key product categories, particularly insecticides, herbicides and fungicides. ✓ SCIL reported revenue of Rs. 907 crore in Q2FY27, down 2% YoY, and Rs. 1,971 crore in H1FY27, down 1%. H1 sales were impacted by lower volumes, partly offset by improved pricing following price increases undertaken during March to June 2026. Q2FY27 witnessed largely stable selling prices; however, sales volumes declined by a high-single-digit percentage, while margins were impacted by the absorption of higher-cost inventory procured during April – June 2026. ✓ Domestic business remained relatively resilient, while exports faced near-term pressure. Q2 domestic revenue grew 2% YoY to Rs. 774 crore, whereas exports declined 23% to Rs. 127 crore. Growth in Metal Phosphides and AND & EHD partially offset weakness across other product categories during H1FY27. ✓ Profitability reflected the timing of inventory cost absorption. Q1FY27 margins had benefited from the consumption of lower-cost opening inventory, while higher- cost inventory procured during Q1 flowed through the cost of sales in Q2FY27, temporarily impacting margins. Consequently, Q2 gross margin declined 240 bps YoY to 40.7% and EBITDA margin contracted 297 bps to 20.5%. However, on a cumulative H1FY27 basis, the margin profile remained broadly comparable to historical levels. ✓ The inventory-cost mismatch substantially normalised by the end of Q2, as procurement costs and selling prices aligned with prevailing market levels. ✓ The Company strengthened its product portfolio with the launch of Topgrain (biostimulant), the first global launch of a promising product developed by its affiliate, Sumitomo Bio-rational Company, USA, and Helibex during Q2FY27. Focused initiatives across key products supported growth in select high-priority molecules. Capital expenditure is progressing as p [Showing first 8,000 characters — download PDF for full document]